Cell signaling through O-GlcNAc reader proteins

通过 O-GlcNAc 读取蛋白的细胞信号传导

基本信息

  • 批准号:
    10656649
  • 负责人:
  • 金额:
    $ 32.04万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2016
  • 资助国家:
    美国
  • 起止时间:
    2016-04-01 至 2027-08-31
  • 项目状态:
    未结题

项目摘要

Project Summary/Abstract O-linked b-N-acetylglucosamine (O-GlcNAc) is a ubiquitous post-translational modification (PTM) in mammals, decorating thousands of nuclear and cytoplasmic proteins. O-GlcNAc cycling is an essential regulator of myriad aspects of cell physiology and is dysregulated in numerous human diseases, such as cancer, diabetes and neurodegeneration. Despite this broad pathophysiological significance, major aspects of O-GlcNAc signaling remain incompletely understood, including the biochemical mechanisms through which O-GlcNAc transduces information. At the start of our project, several studies had shown that O-GlcNAcylation mediates protein-protein interactions (PPIs) in processes as diverse as chromatin remodeling, deubiquitination and nuclear envelope assembly. These results suggested that O-GlcNAc might signal through conserved modes of PPI. However, little was known about either the structure or function of these intracellular glycoprotein-protein complexes. We hypothesized that mammalian “reader” proteins might exist and transduce O-GlcNAc signals. In the first project period, we devised and deployed a method to identify proteins that bind specifically and directly to O- GlcNAcylated peptides and proteins in vitro and in human cells. These include the 14-3-3 family, which are well- known to bind to phosphoproteins. Our results indicate that 14-3-3 proteins may be signal integrators, mediating the extensively documented crosstalk between O-GlcNAc and O-phosphate, with broad implications for intracellular signaling. In addition, we identified and characterized O-GlcNAc-mediated PPIs among nuclear import receptors, intermediate filament (IF) cytoskeleton proteins and ubiquitin E3 ligase complex components. Building on these results, we will study a focused set of diverse model O-GlcNAc-binding proteins in the next project period. This strategy will generate new insight into the functions of individual O-GlcNAc-mediated PPIs in particular cell biological processes, while also providing a comparative perspective across reader proteins, allowing us to discern general themes of O-GlcNAc-mediated PPIs at the biophysical, biochemical and physiological levels. The long-term objective of our work is to understand the principles, mechanisms and functions of O- GlcNAc-mediated PPIs in mammals. In the next project period, we will advance this goal through three Specific Aims. In Aim 1, we will define the biochemical scope and phenotypic effects of O-GlcNAc binding by 14-3-3 proteins. In Aim 2, we will determine the role of O-GlcNAc/nuclear transport receptor interactions in inter-organelle trafficking. In Aim 3, we will dissect the functional importance of O-GlcNAc-mediated interactions in two model IF proteins. We believe our proposed work will significantly advance the field of intracellular signaling both by elucidating the mechanisms and functions of individual O-GlcNAc-mediated PPIs and by revealing conserved biochemical principles of O-GlcNAc recognition across reader proteins.
项目摘要/摘要 O-连接的b-N-乙酰氨基葡萄糖(O-GlcNAc)是一种普遍存在的翻译后修饰(PTM) 哺乳动物,装饰着成千上万的核蛋白和细胞质蛋白。O-GlcNAc循环是一个重要的调节因素 细胞生理学的许多方面,在许多人类疾病中调节失调,如癌症、糖尿病 和神经退化。尽管具有广泛的病理生理意义,O-GlcNAc信号的主要方面 仍然不完全清楚,包括O-GlcNAc转导的生化机制 信息。在我们项目开始的时候,几项研究已经表明O-GlcN酰化是蛋白质-蛋白质的中介 染色质重塑、去泛素化和核膜等过程中的相互作用(PPI) 集合。这些结果表明O-GlcNAc可能通过PPI的保守模式来传递信号。然而,几乎没有 对这些细胞内糖蛋白-蛋白质复合体的结构或功能都是已知的。 我们假设哺乳动物的“阅读器”蛋白可能存在,并转导O-GlcNAc信号。在 在第一个项目期间,我们设计并部署了一种方法来识别特异性和直接与O-结合的蛋白质 体外和人体细胞中的GlcNacyl化多肽和蛋白质。这些人包括14-3-3家庭,他们很好- 已知可与磷蛋白结合。我们的结果表明,14-3-3蛋白可能是信号整合因子,介导 广泛记录的O-GlcNAc和O-磷酸之间的串扰,具有广泛的意义 细胞内信号。此外,我们在核进口中鉴定和表征了O-GlcNAc介导的PPI 受体、中间丝(IF)细胞骨架蛋白和泛素E3连接酶复合体。建房 在这些结果的基础上,我们将在下一个项目期间研究一组不同模型的O-GlcNAc结合蛋白。 这一策略将对单个O-GlcNAc介导的特定细胞PPI的功能产生新的见解 生物过程,同时也提供了读者蛋白质的比较视角,使我们能够识别 O-GlcNAc介导的PPI在生物物理、生化和生理水平上的一般主题。 我们工作的长期目标是了解O-O的原理、机制和功能。 哺乳动物中GlcNAc介导的PPI。在接下来的项目期间,我们将通过三个具体的项目来推进这一目标 目标。在目标1中,我们将定义14-3-3与O-GlcNAc结合的生化范围和表型效应 蛋白质。在目标2中,我们将确定O-GlcNAc/核转运受体相互作用在细胞器间的作用 贩卖人口。在目标3中,我们将在两个模型IF中剖析O-GlcNAc介导相互作用的功能重要性 蛋白质。我们相信,我们提议的工作将显著推动细胞内信号领域的发展, 阐明O-GlcNAc介导的单个PPI的机制和功能并揭示保守的 O-GlcNAc跨阅读蛋白识别的生化原理。

项目成果

期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Site-specific glycosylation regulates the form and function of the intermediate filament cytoskeleton.
  • DOI:
    10.7554/elife.31807
  • 发表时间:
    2018-03-07
  • 期刊:
  • 影响因子:
    7.7
  • 作者:
    Tarbet HJ;Dolat L;Smith TJ;Condon BM;O'Brien ET 3rd;Valdivia RH;Boyce M
  • 通讯作者:
    Boyce M
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MICHAEL S BOYCE其他文献

MICHAEL S BOYCE的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MICHAEL S BOYCE', 18)}}的其他基金

Cell and Molecular Biology Training Program
细胞与分子生物学培训计划
  • 批准号:
    10270808
  • 财政年份:
    2021
  • 资助金额:
    $ 32.04万
  • 项目类别:
Cell and Molecular Biology Training Program
细胞与分子生物学培训计划
  • 批准号:
    10614564
  • 财政年份:
    2021
  • 资助金额:
    $ 32.04万
  • 项目类别:
Cell and Molecular Biology Training Program
细胞与分子生物学培训计划
  • 批准号:
    10434905
  • 财政年份:
    2021
  • 资助金额:
    $ 32.04万
  • 项目类别:
Metabolic regulation of KLHL proteins through O-glycosylation
通过 O-糖基化调节 KLHL 蛋白的代谢
  • 批准号:
    10380171
  • 财政年份:
    2019
  • 资助金额:
    $ 32.04万
  • 项目类别:
Control of COPII vesicle trafficking by intracellular protein glycosylation
通过细胞内蛋白质糖基化控制 COPII 囊泡运输
  • 批准号:
    9750747
  • 财政年份:
    2017
  • 资助金额:
    $ 32.04万
  • 项目类别:
Control of COPII vesicle trafficking by intracellular protein glycosylation
通过细胞内蛋白质糖基化控制 COPII 囊泡运输
  • 批准号:
    9975873
  • 财政年份:
    2017
  • 资助金额:
    $ 32.04万
  • 项目类别:
Control of COPII vesicle trafficking by intracellular protein glycosylation
通过细胞内蛋白质糖基化控制 COPII 囊泡运输
  • 批准号:
    10367509
  • 财政年份:
    2017
  • 资助金额:
    $ 32.04万
  • 项目类别:
Control of COPII vesicle trafficking by intracellular protein glycosylation
通过细胞内蛋白质糖基化控制 COPII 囊泡运输
  • 批准号:
    9384237
  • 财政年份:
    2017
  • 资助金额:
    $ 32.04万
  • 项目类别:
Control of COPII vesicle trafficking by intracellular protein glycosylation
通过细胞内蛋白质糖基化控制 COPII 囊泡运输
  • 批准号:
    10541246
  • 财政年份:
    2017
  • 资助金额:
    $ 32.04万
  • 项目类别:
Cell signaling through O-GlcNAc reader proteins
通过 O-GlcNAc 读取蛋白的细胞信号传导
  • 批准号:
    9901557
  • 财政年份:
    2016
  • 资助金额:
    $ 32.04万
  • 项目类别:

相似海外基金

Targeted ablation of cerebral atherosclerosis using supramolecular self-assembly
利用超分子自组装靶向消融脑动脉粥样硬化
  • 批准号:
    24K21101
  • 财政年份:
    2024
  • 资助金额:
    $ 32.04万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
心房細動に対するPulsed Field Ablationの組織創傷治癒過程を明らかにする網羅的研究
阐明房颤脉冲场消融组织伤口愈合过程的综合研究
  • 批准号:
    24K11201
  • 财政年份:
    2024
  • 资助金额:
    $ 32.04万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
遅延造影心臓MRIによる心房細動Ablation冷却効果の比較:28 vs. 31 mm Cryoballoon
使用延迟对比增强心脏 MRI 比较房颤消融冷却效果:28 毫米与 31 毫米 Cryoballoon
  • 批准号:
    24K11281
  • 财政年份:
    2024
  • 资助金额:
    $ 32.04万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
InSPACE-VT_Development and Validation of Virtual Pace Mapping to Guide Catheter Ablation of Ventricular Tachycardia
InSPACE-VT_虚拟起搏测绘的开发和验证以指导室性心动过速导管消融
  • 批准号:
    EP/Z001145/1
  • 财政年份:
    2024
  • 资助金额:
    $ 32.04万
  • 项目类别:
    Fellowship
CAREER: Heat Penetration Depth and Direction Control with Closed-Loop Device for Precision Ablation
职业:利用闭环装置控制热穿透深度和方向,实现精确烧蚀
  • 批准号:
    2338890
  • 财政年份:
    2024
  • 资助金额:
    $ 32.04万
  • 项目类别:
    Continuing Grant
Collaborative Research: RUI: Frontal Ablation Processes on Lake-terminating Glaciers and their Role in Glacier Change
合作研究:RUI:湖终止冰川的锋面消融过程及其在冰川变化中的作用
  • 批准号:
    2334777
  • 财政年份:
    2024
  • 资助金额:
    $ 32.04万
  • 项目类别:
    Continuing Grant
Collaborative Research: RUI: Frontal Ablation Processes on Lake-terminating Glaciers and their Role in Glacier Change
合作研究:RUI:湖终止冰川的锋面消融过程及其在冰川变化中的作用
  • 批准号:
    2334775
  • 财政年份:
    2024
  • 资助金额:
    $ 32.04万
  • 项目类别:
    Continuing Grant
Collaborative Research: RUI: Frontal Ablation Processes on Lake-terminating Glaciers and their Role in Glacier Change
合作研究:RUI:湖终止冰川的锋面消融过程及其在冰川变化中的作用
  • 批准号:
    2334776
  • 财政年份:
    2024
  • 资助金额:
    $ 32.04万
  • 项目类别:
    Continuing Grant
Cryo laser-ablation system (157+193nm) with 'triple-quad' plasma mass spectrometer, Cryo-LA-ICPMS/MS
带有“三重四极杆”等离子体质谱仪、Cryo-LA-ICPMS/MS 的冷冻激光烧蚀系统 (157 193nm)
  • 批准号:
    515081333
  • 财政年份:
    2023
  • 资助金额:
    $ 32.04万
  • 项目类别:
    Major Research Instrumentation
MRI: Acquisition of a Laser Ablation - Inductively Coupled Plasma - Triple Quadrupole - Mass Spectrometer (LA-ICP-QQQ-MS) System For Research and Education
MRI:获取用于研究和教育的激光烧蚀 - 电感耦合等离子体 - 三重四极杆 - 质谱仪 (LA-ICP-MS/MS) 系统
  • 批准号:
    2320040
  • 财政年份:
    2023
  • 资助金额:
    $ 32.04万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了